James Huang
CIK 1573160 · Chief Executive Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WINT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 300
ROCKVILLE, MD 20850
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTB | Director | 13,310,000 | $0.82 | $10.90M | $4.37M | 2 | 2026-06-02 |
| ATRA | Director | 307,894 | $8.32 | $2.56M | -$4.99M | 3 | 2026-05-11 |
| TCRT | Director | 1,256 | $1.93 | $2.4K | $0 | 3 | 2023-06-08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Director | 84 | $0.01 | $1 | $7.73M | 17 | 2023-02-23 |
| CASI Pharmaceuticals, Inc. (CASI) Delisted | Director | 371,708 | $0.28 | $104.1K | $1.32M | 14 | 2022-09-08 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 108,333 | $0.87 | $93.8K | $171.0K | 3 | 2021-09-03 |
| CASI Pharmaceuticals, Inc. (ENMD) Delisted | Director | — | — | — | $0 | 1 | 2013-05-31 |
Recent Filings · Page 4 of 5
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-07 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Buy (P) | +500 | $2.0K | EDGAR |
| 2020-01-21 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Buy (P) | +2,058 | $8.6K | EDGAR |
| 2020-01-03 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Buy (P) | +15,442 | $62.5K | EDGAR |
| 2019-12-31 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Buy (P) | +5,000 | $18.7K | EDGAR |
| 2019-12-10 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Mixed | +1,752,058 | $5.00M | EDGAR |
| 2019-06-21 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-26 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-03 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-06 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Other (J) | −416,475 | $0 | EDGAR |
| 2017-06-09 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.